Michael P.Earley

Practice Leader Private Equity

Chicago + 1.312.269.4349

Connect:

Share

Michael Earley is co-leader of Private Equity for the Firm's Corporate Practice. For more than 20 years, he has advised fund sponsors, institutional investors, and investment advisors around the globe on a broad range of matters across multiple asset classes, including buyout, private credit, real estate, infrastructure, and venture capital. Michael provides strategic advice to private fund sponsors on their internal structuring, governance, and compensation matters. He also has experience working on M&A transactions involving the sale and minority investments in fund management businesses for sponsors and institutional investors. Michael's work with institutional investors includes work on primary investments, co-investments, direct investments, and secondary transactions.

In addition to his work on private funds, Michael also advises secondaries firms and investors on complex secondaries transactions on a cross-border basis. These include pooled sales of fund interests, stapled transactions, and GP-led (general partner) secondary deals.

In the community, Michael serves as a director of the Western Golf Association Evans Scholars Foundation and a member of board of the Daniel Murphy Scholarship Fund.

Experience

  • Global secondaries manager purchases portfolio of private equity fund interests from institutional asset managerJones Day represented global secondaries manager in connection with the purchase of a portfolio of private equity fund interests from an institutional asset manager.
  • SpiderRock Advisors sold to BlackRockJones Day represented SpiderRock Advisors, LLC, a registered investment adviser that provides customized options overlay strategies for investment portfolios, in connection with the sale of its remaining equity securities to BlackRock, Inc. (NYSE: BLK), the world’s largest asset manager and an existing minority equity holder of SpiderRock.
  • MassMutual invests in Kudu Investment Management, LLCJones Day advised Massachusetts Mutual Life Insurance Company in connection with a minority equity investment in Kudu Investment Management, LLC, which provides long-term capital solutions -- including generational ownership transfers, management buyouts, acquisition and growth finance, as well as liquidity for legacy partners -- to asset and wealth managers globally.
  • Hirtle Callaghan & Co sells portfolio of interests in over 30 private equity fundsJones Day represented Hirtle Callaghan & Co in connection with the sale of a portfolio of interests in over 30 private equity funds.
  • Global secondaries manager purchases portfolio of private equity fund interests with stapled primary investmentJones Day advised a global secondaries manager with the purchase of a portfolio of private equity fund interests in five funds, and a simultaneous primary investment in a private investment fund.
  • Adams Street purchases portfolio of private equity fund interestsJones Day represented Adams Street Partners in connection with the purchase of a portfolio of private equity fund interests.
  • Global secondaries manager purchases portfolio of private equity fund interestsJones Day represented a global secondaries manager in connection with the purchase of a portfolio of private equity fund interests
  • MassMutual enters into approximate $840 million transaction for purchase and financing of natural gas assets located in Pennsylvania and West VirginiaJones Day represented Massachusetts Mutual Life Insurance Company and MassMutual Ascend Life Insurance Company in connection with (a) the acquisition and financing of asset-backed notes and certificates the proceeds of which were used to acquire proved, developed, and producing ("PDP") natural gas assets in Pennsylvania and West Virginia and (b) the formation of a limited partnership and the subsequent acquisition of six proven-undeveloped natural gas wells located in Pennsylvania and West Virgina.
  • Concord Health Partners forms AHA Innovation Development FundJones Day represented Concord Health Partners LLC in connection with the formation of the AHA Innovation Development Fund, LP, a fund focused on investing in early-stage healthcare companies that provide products, services, and solutions to hospitals and health systems.
    • View All

    September 2024 Commentary

    Investment Advisers Subject to AML and SARs Requirements

    June 2024 Alert

    Fifth Circuit Vacates SEC Private Fund Adviser Rules

    April 2024 Alert

    QPAM Amendment Finalized: Prompt Action Required for Continued Reliance

    February 2024 White Paper

    2023 U.S. Real Estate Round-Up: Effects of State ESG Laws on Commercial and Residential Building Owners

    January 2024 Commentary

    What About the Kitchen Sink? FSOC Plans Even More in 2024

    August 2023 Alert

    SEC Adopts Long-Awaited and Heavily Debated Private Fund Adviser Rules

    MAY 2023 Commentary

    FSOC Proposals Renew Threat of Nonbank "Systemically Important" Designations

    March 2023 White Paper

    2022 Annual M&A/PE Review and 2023 Forecast

    September 2022 Alert

    SEC Highlights Compliance With New Advertising Rule

    February 2022 Alert

    SEC's Proposed Rules Target Advisers to Private Funds
    View All

    Additional Speaking Engagements

    • June 7, 2012
      Jones Day Chicago 2012 MCLE University

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.